Effect of PHARMacological treatment in hospitalized patients with Heart Failure

Effect of PHARMacological treatment in hospitalized patients with Heart Failure - PHARM-HF

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000043293

Enrollment

200

Registered

2021-02-12

Start date

2021-02-19

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart failure

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Hospitalized patients with a diagnosis of worsening heart failure defined by the Framingham criteria.

Exclusion criteria

Exclusion criteria: Use of mechanical circulatory support, mechanical ventilation, hemodialysis, and inotropes(dobutamine, noradrenaline, dopamine, epinephrine).

Design outcomes

Primary

Measure	Time frame
Systolic and diastolic blood pressure during hospitalization	—

Secondary

Measure	Time frame
Clinical outcome (death and rehospitalization due to heart failure) on 1 and 2 years after discharge	—

Countries

Japan

Contacts

Public ContactMasaaki Konishi

Yokohama City University Department of Medical Science and Cardiorenal Medicine

m_koni@yokohama-cu.ac.jp0457872800

Outcome results